prighi5.bsky.social
@prighi5.bsky.social
Reposted
Vertex Pharmaceuticals’ suzetrigine, which will be marketed under the name Journavx, targets specific sodium channels that help pass signals on from the site of pain. cen.acs.org/pharmaceutic... #biosky
FDA approves new nonopioid pain medication, hailed a 'triumph'
Vertex’s suzetrigine is a paradigm shift in pain management, the firm’s CEO says
cen.acs.org
February 1, 2025 at 9:41 PM
Reposted
"Research is messy. … Trying to protect students from that reality does them a disservice."

On #InternationalDayOfEducation, take a look back at this #ScienceWorkingLife on teaching students about scientific failure. https://scim.ag/3PLg8ER
January 24, 2025 at 3:07 PM
Reposted
Blood vessels in the brain rhythmically constrict and dilate to drive waves of cleansing fluid through the organ

https://go.nature.com/3PwtwN2
How the brain cleans itself during deep sleep
Blood vessels in the brain rhythmically constrict and dilate to drive waves of cleansing fluid through the organ.
go.nature.com
January 13, 2025 at 11:11 AM
Reposted
As wildfires rage in LA, this graphic in @cenmag.bsky.social looks at one way chemistry can be used to tackle them: cen.acs.org/environment/...

#ChemSky 🧪
January 9, 2025 at 8:30 PM
Reposted
In 2024, the US Food and Drug Administration approved 50 novel molecular entities, down slightly from 55 in 2023. cen.acs.org/pharmaceutic... #biosky #biopharma
50 new drugs received FDA approval in 2024
The agency gave its nod to almost as many new molecular entities last year as it did in 2023
cen.acs.org
January 9, 2025 at 9:25 PM
Reposted
This week is World Antimicrobial Resistance Awareness Week 🦠

This graphic highlights the discovery dates of some key classes of antibiotics – note that no new class of antibiotics has reached the market since 1987

Download & read more here: www.compoundchem.com/2014/09/08/a...

#ChemSky #MedSky 🧪
November 19, 2024 at 8:59 PM